BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10466552)

  • 1. Results of a comprehensive infection control program for reducing surgical-site infections in coronary artery bypass surgery.
    McConkey SJ; L'Ecuyer PB; Murphy DM; Leet TL; Sundt TM; Fraser VJ
    Infect Control Hosp Epidemiol; 1999 Aug; 20(8):533-8. PubMed ID: 10466552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical-site infection rates and risk factor analysis in coronary artery bypass graft surgery.
    Harrington G; Russo P; Spelman D; Borrell S; Watson K; Barr W; Martin R; Edmonds D; Cocks J; Greenbough J; Lowe J; Randle L; Castell J; Browne E; Bellis K; Aberline M
    Infect Control Hosp Epidemiol; 2004 Jun; 25(6):472-6. PubMed ID: 15242194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical site infection rates following cardiac surgery: the impact of a 6-year infection control program.
    Finkelstein R; Rabino G; Mashiah T; Bar-El Y; Adler Z; Kertzman V; Cohen O; Milo S
    Am J Infect Control; 2005 Oct; 33(8):450-4. PubMed ID: 16216658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of postdischarge surveillance on surgical-site infection rates for coronary artery bypass procedures.
    Avato JL; Lai KK
    Infect Control Hosp Epidemiol; 2002 Jul; 23(7):364-7. PubMed ID: 12138973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new surgical-site infection risk index using risk factors identified by multivariate analysis for patients undergoing coronary artery bypass graft surgery.
    Russo PL; Spelman DW
    Infect Control Hosp Epidemiol; 2002 Jul; 23(7):372-6. PubMed ID: 12138975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal trends in the incidence of surgical site infections in patients undergoing coronary artery bypass graft surgery: a population-based cohort study, 1993 to 2008.
    Alasmari FA; Tleyjeh IM; Riaz M; Greason KL; Berbari EF; Virk A; Baddour LM
    Mayo Clin Proc; 2012 Nov; 87(11):1054-61. PubMed ID: 23127732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Intraoperative Continuous-Infusion Versus Intermittent Dosing of Cefazolin Therapy on the Incidence of Surgical Site Infections After Coronary Artery Bypass Grafting.
    Shoulders BR; Crow JR; Davis SL; Whitman GJ; Gavin M; Lester L; Barodka V; Dzintars K
    Pharmacotherapy; 2016 Feb; 36(2):166-73. PubMed ID: 26799442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in the rate of sternal surgical site infection after coronary artery bypass graft: a marker of higher severity of illness.
    Fakih MG; Sharma M; Khatib R; Berriel-Cass D; Meisner S; Harrington S; Saravolatz L
    Infect Control Hosp Epidemiol; 2007 Jun; 28(6):655-60. PubMed ID: 17520536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The standardized incidence ratio as a reliable tool for surgical site infection surveillance.
    Rioux C; Grandbastien B; Astagneau P
    Infect Control Hosp Epidemiol; 2006 Aug; 27(8):817-24. PubMed ID: 16874641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in surgical site infection in patients treated with microbial sealant prior to coronary artery bypass graft surgery: a case-control study.
    Dohmen PM; Gabbieri D; Weymann A; Linneweber J; Konertz W
    J Hosp Infect; 2009 Jun; 72(2):119-26. PubMed ID: 19285360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Medicare claims to rank hospitals by surgical site infection risk following coronary artery bypass graft surgery.
    Huang SS; Placzek H; Livingston J; Ma A; Onufrak F; Lankiewicz J; Kleinman K; Bratzler D; Olsen MA; Lyles R; Khan Y; Wright P; Yokoe DS; Fraser VJ; Weinstein RA; Stevenson K; Hooper D; Vostok J; Datta R; Nsa W; Platt R
    Infect Control Hosp Epidemiol; 2011 Aug; 32(8):775-83. PubMed ID: 21768761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sternal surgical-site infection following coronary artery bypass graft: prevalence, microbiology, and complications during a 42-month period.
    Sharma M; Berriel-Cass D; Baran J
    Infect Control Hosp Epidemiol; 2004 Jun; 25(6):468-71. PubMed ID: 15242193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validating a 3-point prediction rule for surgical site infection after coronary artery bypass surgery.
    Chen LF; Anderson DJ; Kaye KS; Sexton DJ
    Infect Control Hosp Epidemiol; 2010 Jan; 31(1):64-8. PubMed ID: 19911975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An alternative scoring system to predict risk for surgical site infection complicating coronary artery bypass graft surgery.
    Friedman ND; Bull AL; Russo PL; Leder K; Reid C; Billah B; Marasco S; McBryde E; Richards MJ
    Infect Control Hosp Epidemiol; 2007 Oct; 28(10):1162-8. PubMed ID: 17828693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of coronary artery bypass graft surgical site infection surveillance data from a statewide surveillance system in Australia.
    Friedman ND; Russo PL; Bull AL; Richards MJ; Kelly H
    Infect Control Hosp Epidemiol; 2007 Jul; 28(7):812-7. PubMed ID: 17564983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of a 5-year serial infection control and antibiotic stewardship intervention on cardiac surgical site infections.
    Frenette C; Sperlea D; Tesolin J; Patterson C; Thirion DJ
    Am J Infect Control; 2016 Sep; 44(9):977-82. PubMed ID: 27125912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of preoperative antibiotic prophylaxis on surgical site infections complicating cardiac surgery.
    Finkelstein R; Rabino G; Mashiach T; Bar-El Y; Adler Z; Kertzman V; Cohen O; Milo S
    Infect Control Hosp Epidemiol; 2014 Jan; 35(1):69-74. PubMed ID: 24334801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diminishing surgical site infections in Australia: time trends in infection rates, pathogens and antimicrobial resistance using a comprehensive Victorian surveillance program, 2002-2013.
    Worth LJ; Bull AL; Spelman T; Brett J; Richards MJ
    Infect Control Hosp Epidemiol; 2015 Apr; 36(4):409-16. PubMed ID: 25782895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonrandom selection and the attributable cost of surgical-site infections.
    Hollenbeak CS; Murphy D; Dunagan WC; Fraser VJ
    Infect Control Hosp Epidemiol; 2002 Apr; 23(4):177-82. PubMed ID: 12002231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for surgical-site infection following primary total knee arthroplasty.
    Minnema B; Vearncombe M; Augustin A; Gollish J; Simor AE
    Infect Control Hosp Epidemiol; 2004 Jun; 25(6):477-80. PubMed ID: 15242195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.